Followers | 102 |
Posts | 29028 |
Boards Moderated | 3 |
Alias Born | 09/17/2006 |
Monday, March 13, 2023 8:26:38 AM
RiceBran Technologies to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on March 16 at 4:30 p.m. EST
https://finance.yahoo.com/news/ricebran-technologies-host-fourth-quarter-121500177.html
TOMBALL, TX / ACCESSWIRE / March 13, 2023 / RiceBran Technologies (NASDAQ:RIBT), a global leader in the development and production of critical nutritional and functional ingredients derived from small and ancient grains for the healthy food, nutraceutical, pet care and animal feed markets, announced that Peter Bradley, Executive Chairman and Todd Mitchell, Chief Financial Officer, will host a conference call on Thursday, March 16, at 4:30 p.m. EST to discuss the Company's financial results for the fourth quarter ended December 31, 2022.
The call information is as follows:
Date: March 16, 2023
Time: 4:30 p.m. Eastern Standard Time
Toll Free Dial-in number for US/Canada: 888-506-0062
Dial-In number for international callers: 973-528-0011
Participant Access Code: 189245
Webcast: https://www.ricebrantech.com/investors
Following the conclusion of the live call, a replay of the webcast will be available on the Investor Relations section of the Company's website for at least 90 days. A telephonic replay of the conference call will also be available from 7 p.m. EST on March 16, 2023 until 11:59 p.m. EST on March 30, 2023 by dialing 877-481-4010 (United States) or 919-882-2331 (international) and using the passcode 47775
Life is not measured by the number of breaths you take, but by the moments that take your breath away--Wows happen!!!
Recent RIBT News
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/19/2024 08:25:57 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2024 01:43:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 10:01:09 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 07:36:17 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 02:51:19 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 01:28:01 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 01:05:01 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 01:58:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 01:53:02 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 09:26:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 08:24:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 08:06:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/05/2023 01:07:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/05/2023 12:55:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/14/2023 09:25:14 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/31/2023 09:25:49 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/31/2023 09:22:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2023 09:14:16 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/24/2023 09:10:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 08:13:54 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:33:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2023 08:13:04 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM